Bifogade filer
Kurs
+2,91%
Likviditet
0,47 MSEK
Kalender
Tid* | ||
2025-03-13 | 13:30 | Kvartalsrapport 2025-Q3 |
2025-01-08 | N/A | Extra Bolagsstämma 2025 |
2024-11-28 | - | Kvartalsrapport 2025-Q2 |
2024-10-12 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2024-09-16 | - | Kvartalsrapport 2025-Q1 |
2024-06-26 | - | Bokslutskommuniké 2024 |
2024-03-27 | - | Kvartalsrapport 2024-Q3 |
2023-12-21 | - | Kvartalsrapport 2024-Q2 |
2023-11-15 | - | Extra Bolagsstämma 2024 |
2023-10-27 | - | Årsstämma |
2023-10-13 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2023-09-20 | - | Kvartalsrapport 2024-Q1 |
2023-06-23 | - | Bokslutskommuniké 2023 |
2023-05-09 | - | Extra Bolagsstämma 2023 |
2023-03-28 | - | Kvartalsrapport 2023-Q3 |
2022-12-21 | - | Kvartalsrapport 2023-Q2 |
2022-10-31 | - | Årsstämma |
2022-10-14 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2022-09-29 | - | Kvartalsrapport 2023-Q1 |
2022-06-29 | - | Bokslutskommuniké 2022 |
2022-03-21 | - | Kvartalsrapport 2022-Q3 |
2022-03-15 | - | Extra Bolagsstämma 2022 |
2021-12-29 | - | Kvartalsrapport 2022-Q2 |
2021-10-20 | - | Extra Bolagsstämma 2021 |
2021-10-11 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2021-09-29 | - | Kvartalsrapport 2022-Q1 |
2021-06-24 | - | Bokslutskommuniké 2021 |
2021-03-16 | - | Kvartalsrapport 2021-Q3 |
2020-12-14 | - | Kvartalsrapport 2021-Q2 |
2020-10-20 | - | Årsstämma |
2020-10-15 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2020-09-28 | - | Kvartalsrapport 2021-Q1 |
2020-06-25 | - | Bokslutskommuniké 2020 |
2020-03-12 | - | Kvartalsrapport 2020-Q3 |
2019-12-17 | - | Kvartalsrapport 2020-Q2 |
2019-10-16 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2019-10-15 | - | Årsstämma |
2018-09-27 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2018-09-26 | - | Årsstämma |
2018-06-18 | - | Extra Bolagsstämma 2019 |
2018-06-12 | - | Bokslutskommuniké 2018 |
2018-03-12 | - | Kvartalsrapport 2018-Q3 |
2017-09-26 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2017-09-25 | - | Årsstämma |
2017-09-11 | - | Kvartalsrapport 2018-Q1 |
2017-06-19 | - | Bokslutskommuniké 2017 |
2017-03-13 | - | Kvartalsrapport 2017-Q3 |
2017-01-01 | - | Extra Bolagsstämma 2018 |
2016-11-30 | - | Kvartalsrapport 2017-Q2 |
2016-09-06 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2016-09-05 | - | Årsstämma |
2016-09-05 | - | Kvartalsrapport 2017-Q1 |
2016-06-13 | - | Bokslutskommuniké 2016 |
2016-02-22 | - | Kvartalsrapport 2016-Q3 |
2016-02-16 | - | Extra Bolagsstämma 2017 |
2015-11-30 | - | Kvartalsrapport 2016-Q2 |
2015-09-08 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2015-09-07 | - | Årsstämma |
2015-09-07 | - | Kvartalsrapport 2016-Q1 |
2015-06-16 | - | Bokslutskommuniké 2015 |
2015-03-16 | - | Kvartalsrapport 2015-Q3 |
2014-12-01 | - | Kvartalsrapport 2015-Q2 |
2014-10-07 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2014-10-06 | - | Årsstämma |
2014-10-06 | - | Kvartalsrapport 2015-Q1 |
2014-06-30 | - | Bokslutskommuniké 2014 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
Phase Holographic Imaging (PHI) is pleased to announce a strategic expansion into the Spanish and Portuguese markets, facilitated by a new subcontract between its global distribution partner, Altium, and Paralab. As PHI's global distributor partner, Altium has leveraged its autonomy to enhance PHI's market reach, making HoloMonitor technology close at hand to customers on the Iberian Peninsula.
In November 2023, PHI established a distribution agreement with Altium, empowering them to market and sell PHI's products within designated territories. This agreement authorizes Altium to utilize its broad distributor network and global sales contacts, actively opening new markets for PHI's innovative technologies.
Following the agreement, Altium has started to skillfully handle the entire sales process and local customer relations for the HoloMonitor product line. To streamline and improve these efforts, Altium recently appointed Daniel Soor as the dedicated PHI distributor partner manager, significantly enhancing the global reach and sales performance of PHI's HoloMonitor technology.
Building on these efforts, Altium has now advanced PHI's market expansion strategies by entering into a distribution agreement with Paralab. In Spain, the pharmaceutical and biotechnology sectors are not only dynamic but also among the most competitive globally, making this move a pivotal development in PHI's ongoing efforts to expand its international footprint.
PHI's CEO, Patrik Eschricht, expresses:
"We are excited to see HoloMonitor taking a strong market foothold through our collaboration with Altium. Expanding in Spain and Portugal is not merely strategic; it underscores our commitment to advancing global healthcare and research."
About Paralab
Paralab (https://paralab.es/) is a company dedicated to the distribution of scientific instrumentation for laboratories and processes. It represents leading manufacturers of instrumentation for chemical, pharmaceutical and mechanical analysis, focusing its activities on instrumentation sales, technical assistance and user training. Its main objective is to satisfy its customers' needs in terms of quality and service.
Lisa Bodily
E-mail: ir@phiab.com (ir@phiab.se)
Web: www.phiab.com - Live cell imaging & analysis